Bio Medica Laboratories MD, chairman, board of directors and AGM
NSE: BMLLPharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹155.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹188 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 27 Jul 2026
- 16.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 27 Jul 2026
- 44.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Jul 2026
- 0.87
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 50,000100.0% delivered
Bio Medica Laboratories board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Vijay K Jain & AssociatesPeer-review certificate valid to Sep 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Bio Medica Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Bio Medica Laboratories share news and announcements
Annual general meeting, 28 Sep 2026
328 shareholders on the register on 22 Sep 2026; present: 2 promoters and 16 others; votes counted by VISHAKHA AGRAWAL / VISHAKHA AGRAWAL & ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Financial Statement of the company for the financial year ended on March 31, 2026 including the Balance Sheet as at March 31, 2026, the Statement of Profit and Loss Accounts and Cash flow statement for the year ended on that date along with reports of the Board of Director’s and the Auditor’s thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 83.47% · promoters 100.00% · institutions 100.00% · other public 34.49%
- To appoint Mr. Mukesh Mehta (DIN: 03187420) director who retires by rotation in terms of section 152 of the companies act, 2013 and being eligible, offers himself for re-appointment.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 15.78% · promoters 0.00% · institutions 100.00% · other public 34.49%
- Appointment of Secretarial Auditor And Fix Their Remuneration.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 83.47% · promoters 100.00% · institutions 100.00% · other public 34.49%
Increase in limit of total shareholding of all Registered Foreign Portfolio Investors (FPIs) / Registered Foreign Institutional Investors (FIIs) put together up to 49% of the paid-up Equity Share Capital of the Company.MoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 83.47% · promoters 100.00% · institutions 100.00% · other public 34.49%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 27 Aug 2026, 4 resolutions
347 shareholders on the register on 24 Jul 2026; votes counted by Vishakha Agrawal / M/s Vishakha Agrawal & Associates.The company's voting result (opens in a new tab)
- APPROVAL FOR SALE/DISINVESTMENT OF THE SUBSIDIARY COMPANY.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 82.20% · promoters 100.00% · institutions 80.95% · other public 32.34%
- APPROVAL TO ADVANCE LOAN(S), TO GIVE ANY GUARANTEE(S) AND/OR TO PROVIDE ANY SECURITY(IES) UNDER SECTION 185 OF THE COMPANIES ACT, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 82.20% · promoters 100.00% · institutions 80.95% · other public 32.34%
- TO INCREASE IN THRESHOLD OF LOANS/ GUARANTEES, PROVIDING OF SECURITIES AND MAKING OF INVESTMENTS IN SECURITIES UNDER SECTION 186 OF THE COMPANIES ACT, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 82.20% · promoters 100.00% · institutions 80.95% · other public 32.34%
- APPROVAL TO THE RELATED PARTY TRANSACTIONS INCLUDING MATERIAL RELATED PARTY TRANSACTIONS UNDER SECTION 188 OF THE COMPANIES ACT 2013Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 82.20% · promoters 100.00% · institutions 80.95% · other public 32.34%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 23 Jul 2026, 1 resolution
390 shareholders on the register on 19 Jun 2026; votes counted by Vishakha Agrawal / M/s Vishakha Agrawal & Associates.The company's voting result (opens in a new tab)
- TO CONSIDER AND APPROVE THE ALTERATION IN MAIN OBJECTS CLAUSE OF MEMORANDUM OF ASSOCIATION OF THE COMPANY BY ADDITION OF NEW OBJECTSSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 88.48% · promoters 100.00% · institutions 94.19% · other public 45.94%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Jun 2026.
- Fine or penaltyNSESince 30 Jun 2026
Fine imposed due to non submission of Financials results for the Year ended March 31, 2026
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
The company's own answers in its filing.
How money raised was used
The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it.